The adjustment in price target by a reputable analyst firm like Keefe, Bruyette & Woods, while maintaining an Outperform rating, suggests a positive outlook on Lazard's performance but with a slightly moderated growth expectation. This could lead to a neutral short-term impact on the stock as the market absorbs the new price target against the backdrop of continued endorsement of the stock's potential.